ÂÜÀòÂÒÂ×

Stephen Daly is currently the Chief Operating Officer at Abvance Therapeutics since June 2023. Prior to this, Stephen held various leadership positions in companies such as RTMBio, ADOCIA, Halozyme, AFFYMAX, and Amylin Pharmaceuticals. Stephen has a background in marketing and sales, with a strong focus on the pharmaceutical industry. Stephen has also pursued education at Northeastern University and the University of Florida.